insights_auto
Why is BOT down 10.00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0090
arrow_downward
-10.00%(-0.0010) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
10.14M
Volume
947.25K
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
10.14M
Volume
947.25K
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Reuters
·
17 hours ago
S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares
marketscreener.com
·
6 hours ago
S&P 500 Posts Weekly Gain as Energy Sector Leads Broad Climb
qz.com
·
6 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
Traders Union
·
6 hours ago
S&P 500 gains $1.2 trillion in a week, Peter Tuchman notes
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com